Company Profile
Zai Lab Limited Stock Price, News & Analysis
- Ticker:
- ZLAB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- China and listed in the U
Stock performance
20.88 USD (+13.66%)
Close
Last updated: August 6, 2026
1.93B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ZLAB closed up 13.7% at $20.88. No new same-company headline was identified in the current news window.
Company overview
Business overview
Zai Lab is a global biopharmaceutical company focused on oncology, infectious disease, and autoimmune disease. Its story combines commercial execution in Asia with a broad development pipeline and international reach.
Geographic Base and Sector Classification
Zai Lab is headquartered in China and listed in the U.S. market. It sits in global specialty biopharma with a strong oncology footprint.
Business Model Characteristics
The company generates value through product commercialization, pipeline progress, and strategic partnerships across major therapeutic areas. Investors watch revenue growth, approvals, and portfolio expansion.
Position Within the Biotechnology Landscape
Zai Lab occupies a top-tier global biopharma niche. It is more durable than a small-cap biotech name, but pipeline and commercial catalysts still matter a lot.
Future catalysts
Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise. The stock moves on execution across multiple assets.
Recent news
- 01
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Source: Zai Lab Limited
- 02
Zai Lab Announces Participation in November Investor Conferences
Source: Zai Lab Limited
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Zai Lab Limited (ZLAB)?
Zai Lab Limited (ZLAB) most recently closed at 20.88 USD, a +13.66% move versus the previous session.
What is the market cap of Zai Lab Limited (ZLAB)?
Zai Lab Limited currently has a market capitalization of 1.93B USD on BioPharmSignal.
What does Zai Lab Limited do?
Zai Lab is a global biopharmaceutical company focused on oncology, infectious disease, and autoimmune disease. Its story combines commercial execution in Asia with a broad development pipeline and international reach.
On which exchange is ZLAB stock listed?
Zai Lab Limited (ZLAB) is associated with NASDAQ, China and listed in the U, Biopharma.
What is Asia?
Its story combines commercial execution in Asia with a broad development pipeline and international reach.
Which conditions is Zai Lab Limited targeting with Asia?
Zai Lab Limited is associated with oncology, immunology based on its company overview and current catalyst commentary.
How does Zai Lab Limited describe recent progress with Asia?
Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise. The stock moves on execution across multiple assets.
What is China-anchored?
Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise.